Resunab: Completed Phase II enrollment

Corbus completed enrollment of about 44 patients in a double-blind, placebo-controlled, U.S. Phase II trial

Read the full 150 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE